Site search

Clear filter
2892 results for '' found
Randomized trial of medical therapy versus conduction system pacing with AV node ablation in persistent atrial fibrillation [AF] and heart failure with preserved ejection fraction (ACTRN126250004
Randomized trial of medical therapy versus conduction system pacing with AV node ablation in persistent atrial fibrillation [AF] and heart failure with preserved ejection fraction (ACTRN126250004
/
The SPYRAL AFFIRM Global Clinical Study of Renal Denervation with the Symplicity Spyral Renal Denervation System in Subjects with Uncontrolled Hypertension (SPYRAL AFFIRM) (NCT05198674)
The SPYRAL AFFIRM Global Clinical Study of Renal Denervation with the Symplicity Spyral Renal Denervation System in Subjects with Uncontrolled Hypertension (SPYRAL AFFIRM) (NCT05198674)
/
A Multi-Center Evaluation of the Long-Term Safety and Efficacy of Spark-sponsored Gene Therapies in Males with Hemophilia A (NCT03432520)
A Multi-Center Evaluation of the Long-Term Safety and Efficacy of Spark-sponsored Gene Therapies in Males with Hemophilia A (NCT03432520)
/
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (ACTRN12621001444875p)
A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (ACTRN12621001444875p)
/
A PHASE 1, OPEN-LABEL DOSE ESCALATION AND EXPANSION STUDY OF SNV1521 IN PARTICIPANTS WITH ADVANCED SOLID TUMORS (NCT06220864)
A PHASE 1, OPEN-LABEL DOSE ESCALATION AND EXPANSION STUDY OF SNV1521 IN PARTICIPANTS WITH ADVANCED SOLID TUMORS (NCT06220864)
/
Stereotactic ablative body radiation therapy with Nodal Irradiation for ProstatE canceR (ACTRN12625000259448)
Stereotactic ablative body radiation therapy with Nodal Irradiation for ProstatE canceR (ACTRN12625000259448)
/
Phase 1, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of SNDX-5613 in Combination with Intensive Chemotherapy in Participants with
/
A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients with Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or
A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of SNDX-5613 in Patients with Relapsed/Refractory Leukemias, Including Those Harboring an MLL/KMT2A Gene Rearrangement or
/
Sugammadex, neostigmine and postoperative pulmonary complications (the SNaPP Study) (ACTRN12623000394640)
/
Staphylococcus aureus Network Adaptive Platform trial (SNAP) (NCT05137119)
Staphylococcus aureus Network Adaptive Platform trial (SNAP) (NCT05137119)
/
26 27 28 29 30